The efficacy of alfuzosin and solifenacin combination in BPH patients with overactive bladder and low flowrate
Introduction. The alfuzosin and solifenacin combination has previously demonstrated high efficacy and safety in patients with BPH and overactive bladder (OAB), including with severe LUTS, if cases of mechanical type of bladder outlet obstruction (BOO) were excluded. The present study aim was to confirm the efficacy and safety of such combination therapy in patients with severe urinary disorders according to uroflowmetry (UFM).